Veterinary Medicines

Lydaxx 100 mg/ml - Solution for injection (cattle, pigs, sheep)

Authorised
  • Tulathromycin
Download as PDF

Product identification

Medicine name:
Lydaxx 100 mg/ml - Solution for injection (cattle, pigs, sheep)
Active substance:
  • Tulathromycin
Target species:
  • Cattle
  • Sheep
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Tulathromycin
    100.00
    milligram(s)
    /
    1.00
    Vial
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        22
        day
    • Sheep
      • Meat and offal
        16
        day
    • Pig
      • Meat and offal
        13
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        22
        day
    • Sheep
      • Meat and offal
        16
        day
    • Pig
      • Meat and offal
        13
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA94
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Available in:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • France
  • Germany
  • Greece
  • Italy
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
Package description:
  • Packaging:Vial (glass), Package_size:1 vial, Content:50 ml
  • Packaging:Vial (glass), Package_size:1 vial, Content:100 ml
  • Packaging:Vial (glass), Package_size:1 vial, Content:250 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol SA
Marketing authorisation date:
Manufacturing sites for batch release:
  • VETOQUINOL
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 3/05/2024
Download
Bulgarian (PDF)
Published on: 3/05/2024
Download
Croatian (PDF)
Published on: 3/05/2024
Download
Czech (PDF)
Published on: 3/05/2024
Download
Danish (PDF)
Published on: 3/05/2024
Download
Dutch (PDF)
Published on: 3/05/2024
Download
Estonian (PDF)
Published on: 3/05/2024
Download
Finnish (PDF)
Published on: 3/05/2024
Download
French (PDF)
Published on: 3/05/2024
Download
German (PDF)
Published on: 3/05/2024
Download
Greek (PDF)
Published on: 3/05/2024
Download
Hungarian (PDF)
Published on: 3/05/2024
Download
Icelandic (PDF)
Published on: 3/05/2024
Download
Italian (PDF)
Published on: 3/05/2024
Download
Latvian (PDF)
Published on: 3/05/2024
Download
Lithuanian (PDF)
Published on: 3/05/2024
Download
Maltese (PDF)
Published on: 3/05/2024
Download
Norwegian (PDF)
Published on: 3/05/2024
Download
Polish (PDF)
Published on: 3/05/2024
Download
Portuguese (PDF)
Published on: 3/05/2024
Download
Romanian (PDF)
Published on: 3/05/2024
Download
Slovak (PDF)
Published on: 3/05/2024
Download
Slovenian (PDF)
Published on: 3/05/2024
Download
Spanish (PDF)
Published on: 3/05/2024
Download
Swedish (PDF)
Published on: 3/05/2024
Download

ema-puar-lydaxx-v-5199-par-en.pdf

English (PDF)
Published on: 15/03/2023
Download